SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009660
Filing Date
2020-08-06
Accepted
2020-08-06 16:14:12
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20200630x10q.htm 10-Q 1015212
2 EX-10.4 nxtc-20200630ex104568d6b.htm EX-10.4 39296
3 EX-31.1 nxtc-20200630ex311b01798.htm EX-31.1 12135
4 EX-31.2 nxtc-20200630ex3123418fd.htm EX-31.2 11916
5 EX-32.1 nxtc-20200630ex321acb782.htm EX-32.1 12225
  Complete submission text file 0001558370-20-009660.txt   4322449

Data Files

Seq Description Document Type Size
6 EX-101.INS nxtc-20200630.xml EX-101.INS 983177
7 EX-101.SCH nxtc-20200630.xsd EX-101.SCH 26205
8 EX-101.CAL nxtc-20200630_cal.xml EX-101.CAL 35295
9 EX-101.DEF nxtc-20200630_def.xml EX-101.DEF 103165
10 EX-101.LAB nxtc-20200630_lab.xml EX-101.LAB 298355
11 EX-101.PRE nxtc-20200630_pre.xml EX-101.PRE 199201
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 201081791
SIC: 2834 Pharmaceutical Preparations